Hyundai Bioscience Co. Ltd (048410) — Working Capital to Net Assets Ratio
Hyundai Bioscience Co. Ltd (048410) has a Working Capital to Net Assets ratio of 20.8% as of March 2026. Working capital of ₩23.34 Billion (current assets of ₩39.99 Billion minus current liabilities of ₩16.66 Billion) is measured against net assets of ₩111.98 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See financial agility of Hyundai Bioscience Co. Ltd to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Hyundai Bioscience Co. Ltd Working Capital to Net Assets (2014–2025)
This chart shows how Hyundai Bioscience Co. Ltd's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of March 2026, the ratio stands at 20.8%, reflecting working capital of ₩23.34 Billion against net assets of ₩111.98 Billion KRW. See Hyundai Bioscience Co. Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Hyundai Bioscience Co. Ltd (2014–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Hyundai Bioscience Co. Ltd from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Hyundai Bioscience Co. Ltd (048410) market capitalisation.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 22.1% | ₩24.47 Billion | ₩110.73 Billion | ₩43.99 Billion | ₩19.52 Billion | ▲ +74.5 pp |
| 2024 | -52.4% | ₩-20.68 Billion | ₩39.44 Billion | ₩6.81 Billion | ₩27.49 Billion | ▼ -70.6 pp |
| 2023 | 18.1% | ₩8.22 Billion | ₩45.27 Billion | ₩15.16 Billion | ₩6.95 Billion | ▼ -8.7 pp |
| 2022 | 26.8% | ₩15.63 Billion | ₩58.24 Billion | ₩24.01 Billion | ₩8.38 Billion | ▼ -2.7 pp |
| 2021 | 29.6% | ₩18.20 Billion | ₩61.57 Billion | ₩34.85 Billion | ₩16.65 Billion | ▼ -33.5 pp |
| 2020 | 63.0% | ₩32.28 Billion | ₩51.22 Billion | ₩41.86 Billion | ₩9.58 Billion | ▲ +23.2 pp |
| 2019 | 39.9% | ₩18.74 Billion | ₩46.99 Billion | ₩33.27 Billion | ₩14.53 Billion | ▼ -20.0 pp |
| 2018 | 59.9% | ₩24.25 Billion | ₩40.48 Billion | ₩35.69 Billion | ₩11.44 Billion | ▲ +2.0 pp |
| 2017 | 57.9% | ₩17.89 Billion | ₩30.89 Billion | ₩36.37 Billion | ₩18.48 Billion | ▲ +4.2 pp |
| 2016 | 53.7% | ₩9.78 Billion | ₩18.21 Billion | ₩37.68 Billion | ₩27.90 Billion | ▼ -45.5 pp |
| 2015 | 99.2% | ₩24.41 Billion | ₩24.60 Billion | ₩34.12 Billion | ₩9.71 Billion | ▲ +44.9 pp |
| 2014 | 54.3% | ₩12.21 Billion | ₩22.49 Billion | ₩22.15 Billion | ₩9.95 Billion | — |